Ling Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- RNA modifications and cancer
- Cell death mechanisms and regulation
- Extracellular vesicles in disease
- Inflammasome and immune disorders
Papers in
-
- Inflammasome and immune disorders 13
- Cell death mechanisms and regulation 11
- Oncology 68
- Cancer Immunotherapy and Biomarkers 20
- Cancer Cells and Metastasis 12
- Co-authors
- Xun Hu (4 shared papers)Fangming Lin (3 shared papers)Weidong Han (4 shared papers)Anthony Rosenzweig (3 shared papers)Takashi Matsui (3 shared papers)Federica del Monte (2 shared papers)Qiangrong Pan (2 shared papers)Qinghua Lu (2 shared papers)
- Journals
- International Immunopharmacology (6 papers)Scientific Reports (6 papers)Life Sciences (5 papers)Frontiers in Immunology (4 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ling Li
287 papers receiving 7.0k citations
Peers
Comparison fields: 5 of 155
- Cancer Research 1.1k
- Molecular Biology 3.7k
- Immunology 1.0k
- Nephrology 329
- Toxicology 155
Countries citing papers authored by Ling Li
This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).
Fields of papers citing papers by Ling Li
This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 304 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 322 | |
| 2 | 2007 | 316 | |
| 3 | 2005 | 198 | |
| 4 | 2017 | 189 | |
| 5 | 2006 | 167 | |
| 6 | 2010 | 166 | |
| 7 | 2013 | 154 | |
| 8 | 2006 | 135 | |
| 9 | 2008 | 118 | |
| 10 | 2019 | 115 | |
| 11 | 2009 | 112 | |
| 12 | 2020 | 107 | |
| 13 | 2019 | 99 | |
| 14 | 2017 | 92 | |
| 15 | 2016 | 91 | |
| 16 | 2021 | 91 | |
| 17 | 2020 | 80 | |
| 18 | 2014 | 75 | |
| 19 | 2016 | 72 | |
| 20 | 2006 | 72 |
About Ling Li
Ling Li is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Pharmacology, having authored 304 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Autophagy in Disease and Therapy (18 papers), Immune Cell Function and Interaction (17 papers), Inflammasome and immune disorders (13 papers), Cytomegalovirus and herpesvirus research (13 papers), Cancer Cells and Metastasis (12 papers), Immunotherapy and Immune Responses (11 papers) and Cell death mechanisms and regulation (11 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (3.7k citations), Immunology (1.0k citations), Nephrology (329 citations) and Toxicology (155 citations). Ling Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xun Hu, Fangming Lin, Weidong Han, Anthony Rosenzweig, Takashi Matsui, Federica del Monte, Qiangrong Pan, Qinghua Lu, Yasuhisa Fukui and Roger J. Hajjar. Their work appears in journals such as International Immunopharmacology, Scientific Reports, Life Sciences, Frontiers in Immunology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.